chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient under the age of 18 received the 1st dose of the vaccine; A spontaneous report was received from a pharmacist concerning a patient under the age of 18 that received the first dose of Modern's COVID-19 vaccine (mRNA-1273) .  The patient's medical history was not provided.  No concomitant medications were reported.    On an unknown date, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) for prophylaxis of COVID-19 infection.  No laboratory details were provided.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events, patient under the age of 18 received the first dose of the vaccine, was not reported.  The outcome of the event, patient under the age of 18 received the first dose of the vaccine, was considered recovered/resolved.; Reporter's Comments: This case concerns a patient under the age of 18 who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Product administered to patient of inappropriate age without any associated adverse events.
pt recv vax;elev T 104;aching all over,n;to er;
Initial report received from a healthcare professional on 22 May 2013. A patient (demographics unknown) had received a dose of ADACEL vaccine (lot number, dose in series, route and site of administration was unknown) on an unspecified date. The patient's pre-existing physician diagnosed allergies, birth defects, medical conditions and illness at time of vaccination was unknown. Concomitant medications were not reported. On an unspecified date, post vaccination the patient had a reaction to ADACEL. The patient laboratory tests and corrective treatment were not reported. The outcome of event was not reported. Documents held by sender were none.
Initial report received from healthcare professional on 03 JAN 2013. An elderly patient (over 65 years of age) whose gender, initials, medical history and concomitant medications were not reported, had received a dose of FLUZONE HD (batch number, route and anatomical site of administration were not reported) on an unspecified date  It was reported that on unspecified date, after receiving FLUZONE HD, the patient developed Guillain Barre Syndrome. The corrective treatments and laboratory investigations were not reported.  At the time of this report, the outcome was unknown. Documents held by sender: none.
Pt recvd series of 3 hep B vax 16NOV89,19DEC89 & 22MAY90. 26JUL90,titer indicated pt non-responder. Pt recvd booster vax from same lot#;
Around 40 minutes after receiving the second COVID19 vaccination, my heart began racing, I was lightheaded, and my tongue began to swell.  I was taken to an observation room, and a my oxygen saturation was checked.  Because my tongue continued to swell, my chest felt tight, and breathing became shallow, I was injected with 50mg of Benadryl.  I asked for this instead of the Epi pen injection.   The constriction in my chest improved a bit and my tongue started to reduce in size.  I was very sleepy and had the shivers.  After a half hour of resting, I was driven home by family.  The next day I had terrible joint pain, fatigue and chills.  Breathing was fine, but I was easily exhausted by any exertion.  Starting the third day, I was at work teaching and noticed a rapid heart rate, increased chest tightness and extreme fatigue from talking or walking the stairs.  The fourth day I had to leave work early because of the lack of breath and fatigue.  I visited my family doctor who gave me Prednisone and a rescue inhaler, and I started taking the medication. The fifth day my symptoms were the same, but I sat at my desk and was able to do paperwork.  The sixth and seventh days I had to get a substitute for my job, as I did not have enough energy or breath to teach or walk the stairs at school.  I have been on vacation from work since Saturday, a full seven days after the vaccination, and continue to have extreme fatigue and chest tightness with any exertion.   Sunday night I went to the Emergency because I could not get a deep breath and felt like I was suffocating. My oxygen levels were high and my blood pressure good, but the muscles in my neck and chest were constricted making me gasp and choke on my spit.  I was given an albuterol treatment and an anti anxiety drug to help relax me so I could breath normally.  I am still struggling with these symptoms of tight chest, constricted breathing, and extreme fatigue.  But now I am sleeping sitting upright and afraid to fall asleep because I may not be able to breath.
Pt. passed out, 1 day laid back on table shook and sat up direct. Pt. was laid back. Dr notified Dr. visited with pt and pt mom was given soda and rested until no symptoms.
Red spot on back on right side in middle of back.  Feels like a sunburn.  On bra line.  Raised a little, no bumps, no blisters.
COVID-19; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced covid-19. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 was not reported. This report was non-serious. This case, from the same reporter is linked to 20221252811. This report was associated with product quality complaint: 90000264551.
One week after injection my upper arm turned red, was burning and hurt. It went away and then it happened again a week later and it is still red, burning and hurting after 3 1/2 weeks. I went to urgent care a week ago and was told they thought it was a very delayed allergic reaction and was given a six day steroid pack which did nothing. I followed up on the 25th of may with my primary care physician who said it was a delayed immune reaction. She ordered blood work which came back fine and wrote me a letter stating I was advised to avoid the second dose. She said I could wait three months or so and if I felt like it, I could go get the Johnson & Johnson vaccine which I am pretty sure I am not doing as my arm is still red and feels like it?s on fire.
On 10/15.15 at approximately 5 pm, patient received the influenza vaccine. One hour after vaccine, he had a generalized seizure lasting 15 min. During the seizure, mother took child to urgent care center where his temperature was 103 degrees axillary.
Information has been received from a registered pharmacist (R. Ph) concerning a 65 year old female patient with a history of breast cancer who on 28-MAR-2011, was vaccinated with a dose of ZOSTAVAX (Merck), 0.65 ml, subcutaneously in right arm (Lot # 670381/0171AA, expiration date: 07-MAY-2012). On 30-MAR-2011, the patient called to R. Ph to report a red, round swollen, warm to touch area at the injection site. Also, it was reported that the rash seemed to be worse than it was on previous day (29-MAR-2011). The patient did not seek medical attention. Not treatment was given for the adverse event. At the time of the report, the patient had not recovered. Additional information has been requested.
SSHL in the left ear.  100% hearing loss in the left ear, very loud tinnitus, vertigo and loss of balance.
At their 18 year physical patient received a third dose of bexsero when they had already gotten two doses last year. No adverse reaction occurred.
Coughing; Runny nose; Stopped up nose; Sore ribs; Chest congestion; Head congestion; A spontaneous report  was received from a consumer concerning a 72-years-old, female patient who experienced chest congestion, head congestion/stopped up nose , coughing, runny nose, and sore ribs.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 08 Feb 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (lot number: 013M20A) intramuscularly for prophylaxis of COVID-19 infection.   On 17 Feb 2021, the patient reported head congestion that resolved on unknown date. She also reported chest congestion, coughing, runny nose, stopped up nose and sore ribs.  Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events,  chest congestion, head congestion/stopped up nose, coughing, runny nose, and sore ribs, was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt tested + for COVID as out-patient 12/09/2021. Referred to ED due to ongoing dyspnea and hypoxia. Fully vaccinated, has not received booster.  Presented at ED 12/09/2022 and admitted. Date of death: 12/21/2021;  Acute hypoxic respiratory failure , COVID 19 pneumonia
slept poorly; Headache; This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY SLEEP (slept poorly) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY SLEEP (slept poorly) and HEADACHE (Headache). At the time of the report, POOR QUALITY SLEEP (slept poorly) and HEADACHE (Headache) had resolved.            No concomitant medications were reported.  It was reported that the patient experienced headache and slept poorly after receiving the second vaccination dose. The events resolved the following day and the patient did not face any further issues.  No treatment medications were reported.   This case was linked to MOD-2021-067578, US-MODERNATX, INC.-MOD-2021-067578 (E2B Linked Report).; Sender's Comments:  MOD-2021-067578:Dose 1 US-MODERNATX, INC.-MOD-2021-067578:Dose 1
Initial, hives, abdominal pain ( <5 min from getting shot). Within minutes, trouble breathing, emesis. PO BENADRYL given initially before resp distress, no affect IM epinephrine, resolution of symptoms after epinephrine.
10/07 c/o feeling of nausea about 8pm after supper. Pt reports developed temp of 108 F shaking , chills. Temp decreased to 106 rashy 10/08 am. C/O vomiting, diarrhea and shaking chills. 10/9 Temp 103 to 100. By 10/10 temp 99, feeling better. 10/11 afebrile, full recovery per pt. Patient did not call HCP for evaluation.
papular, pruritic rash starting on arms & spreading to legs beginning 1 day p/MMR recvd;
First week after i had extreme fatigue and the second week after i had headaches everydaywith exreme fatigue
Arm soreness; Bruising; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) and CONTUSION (Bruising) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, High cholesterol, Reflux esophagitis, Thyroid disorder and Gout. Concomitant products included ALLOPURINOL for Gout, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced CONTUSION (Bruising). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm soreness). The patient was treated with MENTHOL, METHYL SALICYLATE (SALONPAS [MENTHOL;METHYL SALICYLATE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm soreness) and CONTUSION (Bruising) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient feeling dizzy and passing out, lightheaded. EMS started bolus on patient's left arm and transported to ER
Pt in clinic to get paper work to come back at 1730 to get second covid shot, I was leaving for lunch told her I would give it to her then, since there was no moderna in the clinic we had discussed how many pfizer shots we had left to give and she had been told to come I assumed it was Pfizer. Pt did not have her card at that time but went to get it out of car after giving the vaccine, she gave me her card to put info on I noticed she had been give moderna the first shot assured pt it was icy but I would call and let her  know. She was not upset notified supervisor and database.
administered just liquid portion; administered just liquid portion; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 27-Jul-2022 Reporter's Comments: The pharmacist reported that a nurse administered just the liquid conjugate portion of the Menveo vaccine. Health are professional (HCP) did not have any details at time of call. The reporter consented to follow up via email. Additional Supportive Information: The pharmacist reported that a nurse administered just the liquid conjugate portion of the Menveo vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Was extremely dizzy immediately after in first 10 minutes; Headache; Bad fatigue lasted a week; Bruised at injection site; Had some itching on back and base of skull; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Apr2021 at 12:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included PIDDS (primary immune deficiency syndrome), allergy to oranges (fruit allergy), allergy to milk and a lot of environmental allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. Concomitant medications included clonazepam (MANUFACTURER UNKNOWN); for unknown indication from unknown date and unknown if ongoing. On 20Apr2021 at 12:15, immediately after in first 10 minutes the patient was extremely dizzy, had headache, bad fatigue that lasted a week. The patient experienced bruise at injection site, had some itching on back and base of skull. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely dizzy, headache and bad fatigue lasted a week were recovered on an unknown date in Apr2021; while that of the events bruised at injection site, some itching on back and base of skull were recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Beginning after about 1 day after vaccination, and up until the writing of this report, experiencing itching (intense at times) on arms, hands, chest and back, including intermittent, small hives/lesions, mostly on back of hands and forearms.  Called primary care physician after 2 days and I have been taking an over-the-counter antihistamine , 2-3x per day. Itching has continued, but hasn't gotten worse.
Swelling and induration 2 inches below where injection was given.  No swelling or redness noted around injection site.  Area measure 2 1/2 inches by 2 1/2 inches.  Denies any pain to area.  The swelling started on 4/18/13 according to child.  Instructed to watch for increase swelling and seek further medical attention if necessary, otherwise take Benadryl and ibuprofen.
Patient experienced redness, swelling, itching, and pain at the injection site 1 week after injection.
This spontaneous report as received from a pharmacist refers to 2 unspecified patients of unknown age and gender. Medical history concurrent conditions and concomitant medications were not reported. On unspecified dates, the 2 patients were vaccinated with a dose of ZOSTAVAX (lot # L000449, expiry date: 08-MAR-2016) which were exposed to temperatures outside of the recommended range. No adverse effect was reported. Action taken was not applicable. The outcome of incorrect product storage and no adverse effect was unknown. Additional information has been requested.
A rash on my chest that is also on my arms and neck. There are spots on my legs too. The doctor stated to my that my allergies are hypersensitive most likely from the vaccine. I have had this rash for 5 months now. I have been given a lot of different medications to try and stop the rash but nothing is working. I?m now going to an allergist to try to stop this reaction.  My allergies are on constant overdrive.
she cannot sleep; Initial information was received on 25-Feb-2021 regarding an unsolicited valid non-serious case from a consumer/non-healthcare professional.  This case involves female patient (of an unknown demographics) whom it was reported she cannot sleep, while she received TETANUS TOXOID and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE, TETANUS VACCINE TOXOID [DTP].  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date in 1959 and in 1972, the patient received a dose of suspect TETANUS TOXOID produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date in 1972, the patient received a dose of suspect DTP not produced by Sanofi Pasteur (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious she cannot sleep (sleep disorder) (unknown latency) following the administration of TETANUS TOXOID and DTP.  The patient stated that, she would like to know the ingredients in the DTP vaccine in 1972 as well as the Tetanus vaccine of 1959 and 1972 and she is wanting to know how that would interaction with the COVID vaccine. She said that she had blood poisoning and has a pacemaker. She said her pacemaker is set at 99. Patient does not know the names of the 2 vaccines she got in 1959 and 1972 and is not sure if they were Pasteur either. She said she had a reaction to those and wants to check on ingredients in those 2 vaccines from 1959 and 1972. She mentioned that she cannot sleep. Caller said that she had blood poisoning and has a pacemaker. She does not have names of these vaccines. She is somewhat sure they were Pasteur but not completely sure. Explained to caller that without a brand name we cannot look up ingredients and ingredient list from 1959 and 1972 might be hard to get anyways. Caller said she is wanting to know how that would interaction with the COVID vaccine.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the event outcome was unknown.  There will be no information available on the lot number for this case.
A consumer report has been received. The report concerns an 8 year old, male patient. The reporter reported for two children and this case was related to male child. The patient's medical history and concurrent diseases were not provided. The patient's concomitant medications were not provided. The reporter reported that his children received expired FLUMIST QUARDIVALENT (intranasal) on Monday and they were now having flu like symptoms started on 13-Jan-2014. It was also reported that the patients have had runny nose and were coughing on that day. The Lot number was unknown. The expiry date of FLUMIST QUARDIVALENT was reported as Dec-2013. The patient was not hospitalized. The outcome of the events was unknown. The reporter reported the events of flu like symptoms, runny nose and coughing and assessed them as non-serious. The company physician identified the event of received expired FLUMIST QUARDIVALENT from the case narrative and assessed it as non-serious.
Fever, maximum 104.2.  Patient also had cough, congestion, sneezing, and watery eyes.  The fever lasted 3 days.
intestinal upset; blood in nose mucous; Headache/low grade headache; dizziness; sinus stinging; runny nose; diarrhea; numbness in fingers; tiredness; weakness; This is a spontaneous report from a contactable consumer (the patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration in the left arm on 10Apr2021 13:15 (at the age of 61-years-old) as a single dose for COVID-19 immunization. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. Concomitant medication included azithromycin. The patient previously took and had known allergies to Sulphur. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021, the patient experienced the following events: headache for 2 days, dizziness, then low grade headache for 1 week, sinus stinging and runny nose, blood in nose mucous, diarrhea for 1 week, intestinal upset, numbness in fingers, and overall tiredness and weakness for over one week. No treatment was received for the events. The outcome of the events was recovered in Apr2021. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  Information about the Lot/batch number has been requested.
This case was reported by a health professional in the United States on 08 August 2007. A 14-year-old female patient with no reported medical history received a right deltoid intramuscular injection of Menactra (lot number U2378AA) on 07 August 2007. Less than five minutes following administration, the patient complained of dizziness and increased perspiration, and was placed in a lying position. It was then witnessed that the patient's upper and lower lips began twitching, which lasted approximately five minutes. The patient did not lose consciousness, and pulse and blood pressure "did not change and were okay". The patient recovered.
On 7/4/00, the pt developed a temperature of 102. Rash started on face, neck, chest, and extremities on 7/6/00. Dx with measles.